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Temperate phages drive genomic diversiﬁcation in bacterial
pathogens. Phage-derived sequences are more common in
pathogenic than non-pathogenic taxa, and are associated with
changes in pathogen virulence. High abundance and mobilisation
of temperate phages within hosts suggests that temperate phages
could promotewithin-host evolution of bacterial pathogens. How-
ever, their role in pathogen evolution has not been experimen-
tally tested. We experimentally evolved replicate populations of
Pseudomonas aeruginosa with or without a community of three
temperate phages active in cystic ﬁbrosis (CF) lung infections,
including the transposable phage, ɸ4, which is closely related
to phage D3112. Populations grew as free-ﬂoating bioﬁlms in
artiﬁcial sputum medium, mimicking sputum of CF lungs where
P. aeruginosa is an important pathogen and undergoes evolution-
ary adaptation and diversiﬁcation during chronic infection. While
bacterial populations adapted to the bioﬁlm environment in both
treatments, population genomic analysis revealed that phages
altered both the trajectory and mode of evolution. Populations
evolving with phages exhibited a greater degree of parallel evolu-
tion and faster selective sweeps than populations without phages.
Phage ɸ4, integrated randomly into the bacterial chromosome
but integrations into motility-associated genes and regulators of
quorum sensing systems essential for virulence were selected in
parallel, strongly suggesting that these insertional inactivation
mutations were adaptive. Temperate phages, and in particular
transposable phages, are therefore likely to facilitate adaptive
evolution of bacterial pathogens within hosts.
Pseudomonas aeruginosa j cystic ﬁbrosis j mobile genetic element j
experimental evolution j bacteriophage
INTRODUCTION
Comparative genomics suggests that temperate phages play an
important role in the evolution and genomic diversification of
bacterial pathogens (1). Bacterial genomes often contain a range
of intact and remnant prophage elements (1-3) and ecologically
important bacterial traits are believed to be phage-derived (e.g.
phage-derived bacteriocins (4)). Phage-related sequences are ob-
served more frequently in pathogenic than nonpathogenic strains
(5), and prophage acquisition can be associated with changes
in pathogen virulence (6, 7). Prophages can directly contribute
accessory gene functions (1, 8), or disrupt bacterial genes by
insertional inactivation. Of particular note are the transposable
class of temperate phage (also known as mutator phage), includ-
ing D3112 of P. aeruginosa (9, 10), which integrate throughout
the chromosome disrupting existing genes and increasing the
supply of mutations available to selection. Recent reports of high
rates of phage mobilization within hosts (11) and high temperate
phage abundance in humans (12), including at sites of chronic
infection where phage particles have been observed to exceed
bacterial host densities by 10-to-100-fold (13), suggests that tem-
perate phages could play an important role in driving within-
host evolution of bacterial pathogens. However, experimental
tests of the hypothesis that temperate phages contribute to rapid
evolutionary adaptation of pathogenic bacteria are lacking.
Pseudomonas aeruginosa is an important opportunistic
pathogen and the major cause of chronic lung infection leading
to morbidity and mortality in Cystic Fibrosis (CF) patients (14).
Populations of P. aeruginosa in the CF lung grow as microcolony
biofilms suspended within lung sputum and undergo extensive
genetic diversification (15-17) and rapid evolutionary adaptation
(18, 19) to this host environment. Characteristic bacterial adap-
tations to life in the CF lung and the transition to chronicity
include the evolution of mucoidy, altered metabolism, loss of
motility, quorum sensing defects, and resistance to antibiotics
(18, 20). Despite detailed knowledge of the targets of selection,
we still have only a very limited understanding of the causes of
selection driving the evolution of these phenotypes. Phages are
known to be present in the CF lung, have been cultured from
lung sputa (21, 22) and detected at high abundance using culture
independent molecular approaches (13). Moreover, prophages
are a common feature of P. aeruginosa sequenced genomes (23),
and lysogenic conversion has been linked to the evolution of
key clinical phenotypes (e.g., mucoidy (24, 25)). Therefore it is
likely that temperate phages may both impose selection on P.
aeruginosa in the CF lung, and contribute to pathogen adaptation
to this host environment.
We used experimental evolution to directly test how temper-
ate phages affect P. aeruginosa adaptation in artificial sputum
Signiﬁcance
During chronic infection bacterial pathogens undergo rapid
evolutionary adaptation and extensive genetic diversiﬁcation
affecting patient symptoms and treatment outcomes. Tem-
perate phages are common in pathogen genomes and phage
particles can reach high abundance in human infections, but
their role in pathogen evolution is unclear. Using experimental
evolution and population genomics we show that temperate
phages found in human infections accelerated pathogen evo-
lution by increasing the supply of beneﬁcial mutations and
imposing strong selection on bacterial populations. Notably
phages accelerated the loss of clinically important virulence-
related bacterial traits, including motility and quorum sensing.
Temperate phages are likely therefore to facilitate rapid evolu-
tion of bacterial pathogens and contribute to their adaptation
to the host environment and clinical treatments.
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Fig. 1. | Fitness response to selection in populations evolving with and
without phages. Data points represent the mean ± 1 S.E. ﬁtness calculated as
selection rate for populations evolved with (ﬁlled symbols) or without (open
symbols) phages in competition against either ancestral PAO1, or an isogenic
phage-resistant competitor, PAO1ΔpilA.
medium (ASM), an in vitro environment that recapitulates key
physiochemical and biofilm growth properties of CF lung sputum
(26). Specifically, we propagated 6 replicate populations of P.
aeruginosa PAO1 in the presence versus absence of an assemblage
of 3 temperate phages (LESɸ2, ɸ3 and ɸ4) for approximately 240
bacterial generations. These temperate phages naturally coexist
as prophages in the genome of the P. aeruginosa Liverpool Epi-
demic Strain (LESB58) (27), the dominant clone infecting the
UK CF population (28), and contribute to its competitiveness in
vivo (27, 29, 30). Whereas ɸ2 and ɸ3 are insertion site specific,
ɸ4 is closely related to D3112, which is known to insert ran-
domly throughout the P. aeruginosa chromosome (9, 10), and may
therefore play an important role in facilitating the evolutionary
adaptation of P. aeruginosa by increasing mutational supply. All
phages display high rates of lytic activity in chronic CF lung
infections (13), including being induced into the lytic cycle by
clinically relevant antibiotics (21).
RESULTS AND DISCUSSION
In the experimental populations, phages had no effect on bacte-
rial densities (Fig S1a) despite evidence of on-going phage lysis in
all replicate populations of the phage treatment (Fig S1b). At the
end of the experiment, free virions of all phages were detected
in 4/6 populations, whereas in the other 2 populations only ɸ3
and ɸ4 virions were detected (Fig S1c). We observed high rates
of lysogeny (i.e., integration of prophage(s) into the bacterial
chromosome) in 5/6 populations but the phages differed in their
propensity to form lysogens: lysogens of the transposable phage
ɸ4 approached fixation in 5/6 populations, whereas lysogenisation
of bacteria by the other phages was less common, and, where ob-
served, was typically as a polylysogen in combination with ɸ4 (Fig
S2). Thus lysogeny, and indeed polylysogeny, was rapidly estab-
lished in our experimental populations, and moreover lysogeny
appears to have been essential for the long-term maintenance of
phages in populations.
To determine the fitness response to selection we competed
each evolved population against the ancestral PAO1 in ASM, and
because lysogens may have higher fitness simply due to phage-
mediated killing of susceptible competitors (29, 31), we also per-
formed competitions against a phage-resistant PAO1ΔpilA (all of
the temperate phages used here infect via the type IV pilus (32)).
We observed that evolved populations from both treatments were
fitter relative both to PAO1 and PAO1ΔpilA (Fig 1; one-sample
t-test (alt=0), all significant at an alpha-level of 0.0125). Popu-
lations evolved with phages had higher fitness than populations
evolved without phages relative to PAO1, but this fitness advan-
tage of evolving with phages was lost when competing against
PAO1ΔpilA (Fig 1; treatment × competitor interaction: F1,20=
8.54, MSE = 0.59, p < 0.01; simple effect of treatment against
competitor PAO1: F1,10= 7.12, MSE = 0.71, p < 0.025; simple
effect of treatment against competitor PAO1ΔpilA: F1,10= 1.53,
MSE = 0.06, p= 0.24). Together these data confirm that popula-
tions in both treatments adapted to the sputum-like environment
and that lysogenised hosts had enhanced competitiveness against
phage-susceptible competitors.
To determine the genetic basis of the observed evolutionary
adaptation we performed whole genome sequencing on popula-
tion samples containing 40 random clones pooled per popula-
tion from the end of the experiment. All populations contained
single nucleotide polymorphisms (SNPs) and small insertions or
deletions (indels), and all replicate populations that had evolved
with phages contained integrated prophages. At the genome-
wide scale, populations evolved with or without phages did not
differ in abundance or frequency of SNPs and indels (excluding
insertions caused by prophage integrations) and both groups had
high variance of polymorphic sites: between 16 and 173 among
the phage-free populations and 17 to 176 among the phage-
containing populations (Table S1).
Parallel evolution at a particular locus, where independent
mutations are observed more often than expected by chance,
is strong evidence for positive selection. For example, in the
absence of selection, the probability of observing a mutation in
two populations at the conclusion of the experiment is only p
= 0.003, and p = 0.0002 if observed in three populations (for
an average 1004 bp sized protein coding sequence in the PAO1
genome). Thus to identify loci likely to have been under selection
during experimental evolution we concentrated our analyses on
the subset of genes that had been targeted by mutations in ≥2
replicate populations per treatment (Fig 2, Tables S2 and S3). A
greater degree of parallel evolution was observed in the presence
of phages (measured as the probability of randomly drawing a
pair of mutated genes from different populations, with phages
0.056 ± 0.016 s.e., without phages 0.024 ± 0.007 s.e., p < 0.05 by
Bootstrap Test). Some parallel targets of selection were shared
among treatments, including genes involved in the type IV pilus
motility, flagellar motility, biofilm formation, metabolism and
regulation, suggesting that these mutations were beneficial in
the sputum-like environment per se. Interestingly, some loci were
more likely to evolve in the presence of phages. In particular,
mutations affecting the quorum sensing (QS) regulators lasR and
mvfR were each observed in 5/6 replicate phage-treated popula-
tions, compared to only 1/6 replicate phage-free populations. In
addition, 3/6 populations evolving with phages versus 1/6 evolving
without phages contained mutations in fha1, which encodes an
FHA domain protein that post-translationally activates type VI
secretion (33). A further indication of stronger selection due
to phages is that parallel selected loci displayed higher allele
frequencies in the phage treatment (mean allele frequency =
34.33 ± 3.2 s.e.m / 40) compared to the control treatment (mean
allele frequency = 22.67 ± 3 s.e.m. / 40), suggesting that selective
sweeps in the phage treatment were closer to fixation (discussed
in more detail in Supplementary Materials).
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Fig. 2. | Genetic loci under positive selection as indicated by parallel genomic evolution in populations evolving with and without phages. Each concentric
circle corresponds to a replicate population in either the control (without phages) or treatment group (with phages), as indicated. Positions around each
concentric circle, starting at the 12 o'clock position and in a clockwise direction, correspond to positions around the published P. aeruginosa PAO1 single
circular chromosome. The smaller circles around each concentric circle indicate the positions of variants in each replicate that were observed in an open
reading frame under positive selection i.e., mutated in parallel in at least one other replicate. Only variants in fha1 were at precisely the same position and
were likely to be homologous. Variants are also listed in Table S8.
A key difference between the populations evolving with,
versus without phages is that a substantial fraction of ORFs
under positive selection (8 of 26; figure 2) contained mutations
caused by prophage integration in the phage-containing treat-
ment. Prophage 2 and 3 were found exclusively at the intergenic
sites homologous to their positions in the LESB58 chromosome
from where they were isolated (4,629,220 bp and 4,103,724 bp
in the PAO1 chromosome) and were therefore excluded from
analyses. In contrast ɸ4 integrations were observed at 19 different
positions across the 6 replicates, suggesting that ɸ4 integration
provided an additional source of genetic diversity for selection to
act upon. Although ɸ4 is closely related to D3112 and therefore
likely to integrate randomly throughout the chromosome (27,
32, 34), we tested for hotspots of integration with an exhaustive
search of sequence motifs using the MEME and MAST algo-
rithms (35, 36) in the 1000 bp region around each of the inte-
gration sites. Only very weakly conserved motifs were identified
(Table S4), suggesting that ɸ4 has the low integration specificity
characteristic of transposable phages like D3112. Despite the
very low integration specificity of ɸ4, all of the 19 integration
sites were located within or adjacent to only 7 different operons,
which is consistent with positive selection for integrations at those
regions (Fig 2; Tables S5 and S8). The functions most commonly
predicted to be disrupted by positively selected ɸ4 integration
events were type IV pilus motility and QS. Thus transposable
temperate phages like ɸ4 may commonly alter the mode of bac-
terial evolution by increasing the supply of mutations available to
natural selection.
Because all of the temperate phages used here infect via the
type IV pilus (32) and PAO1ΔpilAmutants showed higher fitness
compared to PAO1 against lysogenized bacteria evolved in the
phage treatment (Fig 1), we hypothesised that disruption of type
IV pilus motility associated genes may have been selected to
prevent superinfection and lysis of ɸ4 lysogens. Notably, while
ɸ4 lysogens have strong superinfection immunity against ɸ4, they
remain susceptible to infection and subsequent lysis by ɸ2 and
ɸ3 (32), suggesting that loss of type IV pili could be beneficial
in the presence of a diverse phage community. In support of this
we observed higher rates of phage resistance in populations that
evolved with versus without phages (Fig 3a; Mann–Whitney test;
W = 24.0, n1 = n2 = 6, p = 0.02). Correspondingly, type IV
pilus-dependent twitchingmotility was lostmore rapidly in phage-
containing populations than in phage-free populations, suggest-
ing that the loss of type IV pilus function was more strongly
selected in the presence of phages (Fig 3b). To determine whether
loss of type IV pilus twitching motility phenotype was associated
with ɸ4 integration, we tracked allele frequency dynamics in 2
replicate populations. Specific PCR primer sets (Table S6) were
used to detect integrated ɸ4 prophage in fimU and pilV . In both
cases therewas a positive association between the allele frequency
dynamics and the rise in frequency of twitching motility deficient
mutants (Fig 3c). We next contrasted the allele frequencies of
SNPs, indels and ɸ4 prophage-integration mutations occurring at
type IV pilus associated loci. Across 6 phage-treated populations,
12 mutations of the type-IV pilus associated genes were detected
in parallel, the majority (n=9) were caused by ɸ4 prophage-
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Fig. 3. | The evolution of resistance to phages and pilus-dependent twitch-
ing motility traits. (A.) Boxplot of phage resistance in endpoint populations.
The thick horizontal line denotes the median frequency of isolates resistant
to one or more LES phages in a population for each treatment. Asterisks and
narrow horizontal lines denote outliers and the upper and lower quartiles,
respectively. (B.) Frequency of bacterial isolates in each population through
time displaying impaired twitchingmotility. (C.) Allele frequency dynamics of
LESω4 integrated intoﬁmU and pilV for populations P7 and P11, respectively,
and loss of twitching motility in these populations. Closed black circles and
open white diamonds represent populations P7 and P11, solid grey lines
twitching motility data, and dashed black lines allele frequency data.
integration, and half of them (n=6/12) occurred at high frequen-
cies (≥10/40 clones per population). However, in the absence of
phages, while more mutations were detected in these genes in
parallel (n=16), only 13% of these mutations occurred at high
frequency (Table S3). Consistent with the phenotypic data (Fig.
3b, c), this suggests that there was stronger positive selection
for mutations disrupting type IV pilus associated genes in the
presence of phages, driving faster selective sweeps, compared
to type IV pilus disrupting mutations occurring in the absence
of phages. The exception to this pattern is replicate 3 of the
phage treatment, where the impairment of twitchingmotility in 35
isolates can be explained by a single frame-shift deletion variant at
35/40 in pilY1 (PA4554; encodes a type IV pili biogenesis protein;
Fig 2). It is notable that a low frequency of lysogeny was observed
in this population, unlike all other phage treatment replicates
where lysogens approached fixation (Fig S2).
Our genomic data suggest that temperate phages promoted
the loss of QS with positive selection of ɸ4 prophage integrations,
SNPs and indel mutations at the mvfR and lasR loci. Mutations
to lasR lead to disruption of the acyl-homoserine-lactone (AHL)
signaling system (37), whereas mutations to mvfR lead to dis-
ruption of the Pseudomonas Quinolone Signal (PQS) system
(38), suggesting large-scale alterations to QS cell-cell signaling
in populations evolving with phages. To test whether QS defi-
cient bacteria have higher fitness in the presence of phages, we
competed PAO1 against PAO1ΔlasR in ASM with and without
the temperate phages. There was no effect of phages on the
fitness of PAO1ΔlasR (Fig. S3; two-sample t-test, t10 = -0.7989,
p= 0.44), which was substantially fitter relative to PAO1 in both
the presence (one-sample t-test (alt=0), t5 = 5.0331, p <0.01)
and absence (one sample t-test (alt=0), t5 = 6.7065, p = 0.001)
of phages. These data suggest that lasR mutations are beneficial
in ASM per se. This is consistent with the observation that single
populations in the phage-free treatment also acquired mutations
in QS genes, but suggests that the rate of evolution at these loci
was higher in the presence of phages. Secondly, we compared
the rates of spontaneous phage lysis of ɸ4 lysogens constructed
in both the PAO1 and PAO1ΔlasR backgrounds: There was no
significant difference in production of free phages in stationary
phase cultures (median free phage density: PAO1, 3.4 x 108 p.f.u.
per ml, PAO1ΔlasR, 3.3 x 108 p.f.u. per ml; Mann-Whitney test;
W = 92.0, P = 0.345). Thus although direct interaction between
temperate phages and bacterial QS has been reported in other
systems, viaQS induced lysis by phages (39) orQSmediated alter-
ation of phage receptor expression by bacteria (40), this does not
appear to be an important factor in our study. Phages may have
simply increased the supply of large effect mutations available to
natural selection, notably via ɸ4 prophage integrations intomvfR
(Fig 2). Alternatively, there may have been epistatic interactions
between the fitness effects of QS mutations and other positively
selectedmutations, which strengthened selection for loss of QS in
the presence of phages.Mutations inQS regulators are commonly
observed to accumulate over time in CF chronic infection (41).
Both AHL and PQS signaling are required for full virulence in
P. aeruginosa (42) suggesting that temperate phage selection may
accelerate the loss of virulence in chronic infections.
In summary, we have shown that temperate phages enhanced
parallel evolution in P. aeruginosa biofilms in a sputum-like en-
vironment. Our data suggest two ways in which this may have
occurred: Firstly, the transposable phage ɸ4 mediated adaptive
evolution by increasing the supply of positively selectedmutations
via insertional inactivation of genes caused by prophage integra-
tions, particularly in type-IV pilus and QS associated genes. Sec-
ondly, we present evidence that temperate phage strengthened
selection, particularly for mutations in type IV pilus associated
genes, accelerating the evolutionary loss of type IV dependent
pilusmotility presumably to avoid super-infection and subsequent
lysis by phages which infect via the type IVpilus. A recent transpo-
son sequencing study of P. aeruginosa PA14 shows that mutations
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in type IV pilus associated genes increase fitness in the murine
lung (43). Moreover, loss of both motility (44, 45) and QS (46, 47)
functions are known to frequently evolve in P. aeruginosa chronic
infections of the CF lung. Temperate phages, including those
used here, can be present at very high densities in the CF lung
(exceeding bacterial densities by orders ofmagnitude (13)), which
taken together with our findings suggests that temperate phages
could play an important role in CF lung infections by driving the
evolution of these clinically important traits in P. aeruginosa. In
addition, our data suggest that living in a sputum-like environ-
ment per se selects for mutations in genes associated withmotility,
biofilm formation, metabolism and regulation. Similar mutations
observed in CF lung isolated P. aeruginosa are therefore likely to
be at least partially explained simply as adaptations to selection
imposed by the sputum environment, but could have implications
for susceptibility to antibiotics (48) or host immune responses
(49) as correlated responses (50). Experimental evolution in
clinically relevant infection models has the potential to enhance
our understanding of the causal links between sources of selection
and the evolutionary responses of pathogens in infections (51),
advancing our understanding of within host pathogen evolution
and our ability to direct this for improved patient health.
METHODS SUMMARY
Twelve replicate microcosms (30 ml glass universals contain-
ing 5 ml ASM) were inoculated with 5 x 107 cells P. aeruginosa
strain PAO1 and grown as a biofilm (37 °C incubation with
shaking at 60 r.p.m.). LES phages φ2, 3 and 4 were added to
six microcosms after 24 hours of growth to a total multiplicity of
infection of 0.1 (phage treatment), and the remaining six were
designated phage-free controls. Phages were added only once,
at the beginning of the experiment. After a further 72 hours
growth, biofilms were homogenized with an equal volume of
Sputasol and the homogenate transferred (1:100) into freshASM.
Transfers were repeated every 4 days, to a total of 30 transfers
(approximately 240 bacterial generations). Every other transfer,
bacterial and total free phage densities were enumerated, and
every 5 transfers, the frequency of prophage carriage in the
phage treatment was estimated with a multiplex PCR assay using
primers targeted to each of the LES phages. At transfers 5, 15
and 30, 40 isolates per population were screened for the type IV-
pilus mediated twitching motility phenotype using the agar stab
method.
At the end of the experiment, DNAwas extracted from 40 iso-
lates per population and pooled, and the pooled DNA sequenced
on an Illumina HiSeq 2000. European Nucleotide Archive acces-
sion number for the project is PRJEB9801. Polymorphisms were
called from reads aligned to the published PAO1 genome treating
each sample as having ploidy = 40, reflecting the number of
pooled isolates. ɸ4 prophage insertion sites were estimated from
themapping locations of reads that mapped to the PAO1 chromo-
some and whosemate readmapped to the ɸ4 prophage sequence.
The MEME software suite (35, 36) was used for motif analysis.
First, the 20 most conserved motifs at ɸ4 prophage integration
sites were selected using the MEME algorithm. Second, the
entire host chromosomewas searched formotif occurrences using
the MAST algorithm (see supplementary materials for details).
Frequencies of each prophage integration site were estimated
based on the number of read pairs split between prophage and
reference chromosomes as a proportion of read pair depth in
that region. Open reading frame (ORF) annotations from the
published sequence were supplemented using the STRING v10
database (52). Counts of ORFs affected by mutations in more
than one population per treatment were implemented using the
BioPython library ver. 1.65 (53) and chromosome map plots
implemented using the svgwrite library ver. 1.1.3 in Python ver.
2.7.10. Included in the parallel selected loci were those exhibiting
the “multi-diverse” signature of unlinked polymorphisms in the
same ORFs. The method is implemented in the CheckLinkage
option of BAGA (http://github.com/daveuu/baga) (54) and dis-
cussed in the Supplementary Materials.
Relative free phage abundances in endpoint populations
were estimated separately for each phage using a qPCR as-
say of DNAse-treated supernatants, using primers targeted to
each phage, and comparison to a set of standards of known
concentration. Competitions were performed between endpoint
populations against the ancestral PAO1 (labelled with a gen-
tamicin resistance marker), or an isogenic LES phage-resistant
competitor, PAO1ΔpilA (labelled with a tetracycline resistance
marker), in conditions identical to one transfer of the selection
experiment. The density of each competitor was determined by
plating onto antibiotic selective and non-selective media. Fit-
ness was calculated as the selection rate constant. Free phage
densities were measured for LESφ4 lysogens in both PAO1 and
PAO1ΔlasR. Ten independent lysogens were constructed in each
host background (PAO1 and PAO1ΔlasR) and cultured in LB
until stationary phase, and free phage densities in the supernatant
quantified using a plaque assay. Full methods are included in the
supplementary information.
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